Lanxess AG reported fourth quarter adjusted EBITDA of €102 million, slightly surpassing the €100 million analysts had forecast. Group sales for the quarter amounted to €1,268 million, however, coming in below the €1,322 million consensus.
On an organic basis, sales fell 6%, driven by a 4% decline in volumes and a 2% reduction in pricing. Additional factors hit reported sales: portfolio effects subtracted 4% while currency translation reduced sales by a further 4%. The company said adjusted EBITDA margins narrowed by 270 basis points compared with the same period a year earlier.
2026 outlook and near-term operating cadence
For 2026 Lanxess provided guidance for adjusted EBITDA in a €450 million to €550 million range. The guidance midpoint - €500 million - is 3% below the analyst expectation of €516 million. Management also signaled that it does not expect sequential operational improvement in the first quarter, a view that contrasts with analyst estimates of €126 million for Q1.
The company reiterated that its exposure to the Middle East remains below 2% of total operations.
Business-segment detail
Advanced Intermediates recorded adjusted EBITDA of €18 million in the quarter, underperforming the €26 million consensus. Segment sales totaled €354 million, down 10% on an organic basis, with volumes falling 9%. The division continued to face pressure from soft end markets and competition from Asian producers, and adjusted EBITDA margins compressed by 650 basis points. Management expects earnings in 2026 to be slightly above 2025 levels, citing increased utilization supported by peer consolidation as the driver.
Specialty Additives generated adjusted EBITDA of €46 million, ahead of the €43 million estimate. Sales were €478 million, a 3% organic decline as volumes decreased 4%, partially offset by a 1% increase in prices. Margins in the division expanded by 50 basis points. The company noted weaker volumes in Rhein Chemie, though flame retardants posted slightly positive volume growth. Specialty Additives is expected to deliver 2026 earnings slightly above 2025.
Consumer Protection posted adjusted EBITDA of €58 million, below the €68 million consensus. Sales in the division were €434 million, down 7% organically as prices fell 7% while volumes remained flat. Management attributed lower prices to weak agricultural markets and the pass-through of reduced input costs. Adjusted EBITDA margins contracted by 420 basis points. The division anticipates 2026 earnings slightly below 2025, in part because one-time effects that supported prior-year results are absent.
Cash flow and balance sheet
Operating cash flow in the fourth quarter amounted to €209 million, down from €352 million in the prior-year period. Free cash flow was €64 million, compared with €206 million a year earlier. Net financial debt stood at approximately €2.023 billion, which the company reported as representing 4.0 times net debt to adjusted EBITDA.
The board declared a dividend of €0.1 per share, matching analyst expectations.
Implications
The quarter shows a split between modest outperformance on headline adjusted EBITDA and softer top-line dynamics, with portfolio actions and currency effects amplifying organic weakness. Division-level trends vary: Advanced Intermediates faces ongoing market and competitive pressure; Specialty Additives delivered a beat driven by relative margin resilience; Consumer Protection saw price-led declines tied to agricultural demand.
Investors and market participants will likely focus on the company’s ability to translate the stated utilization gains and peer consolidation into clearer earnings progression in 2026, while monitoring cash flow recovery and leverage metrics following the year-on-year deterioration.